Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |